+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Liver And Kidney Disorders Drugs Market Research Reports

Hepatitis B Infection Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Hepatitis B Infection Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
IgA Nephropathy Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

IgA Nephropathy Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) Treatment Market Report and Forecast 2023-2031

  • Report
  • March 2023
  • 147 Pages
  • Global
From
Focal Segmental Glomerulosclerosis (FSGS) Treatment Market - Global Forecast Report 2023-2031 - Product Thumbnail Image

Focal Segmental Glomerulosclerosis (FSGS) Treatment Market - Global Forecast Report 2023-2031

  • Report
  • March 2023
  • 147 Pages
  • Global
From
Hepatitis C Drug Market - Product Thumbnail Image

Hepatitis C Drug Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
End Stage Renal Disease Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

End Stage Renal Disease Market Analysis & Forecast to 2024-2034

  • Report
  • May 2024
  • 200 Pages
  • Global
From
Liver Disease Treatment Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Liver Disease Treatment Market Analysis & Forecast to 2024-2034

  • Report
  • May 2024
  • 200 Pages
  • Global
From
Polycystic Kidney Disease Market - Product Thumbnail Image

Polycystic Kidney Disease Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
Primary Biliary Cholangitis Therapeutics Market - Product Thumbnail Image

Primary Biliary Cholangitis Therapeutics Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Chronic Kidney Disease Market Analysis & Forecast 2024-2034: Market By Product (Diagnosis, Treatment; By Route of Administration; By End-user; and By Region - Product Thumbnail Image

Chronic Kidney Disease Market Analysis & Forecast 2024-2034: Market By Product (Diagnosis, Treatment; By Route of Administration; By End-user; and By Region

  • Report
  • October 2023
  • 145 Pages
  • Global
From
Cystinosis - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Cystinosis - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Alagille syndrome - Epidemiology Forecast to 2032 - Product Thumbnail Image

Alagille syndrome - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Alagille Syndrome - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Alagille Syndrome - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Non-Alcoholic Steatohepatitis Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product, Application, and Sales Channel - Product Thumbnail Image

Non-Alcoholic Steatohepatitis Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product, Application, and Sales Channel

  • Report
  • April 2022
  • 178 Pages
  • Global
From
Asia Pacific Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product; End User; and Country - Product Thumbnail Image

Asia Pacific Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product; End User; and Country

  • Report
  • November 2020
  • 155 Pages
  • Asia Pacific
From
Middle East and Africa Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product; End User; and Country - Product Thumbnail Image

Middle East and Africa Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product; End User; and Country

  • Report
  • November 2020
  • 164 Pages
  • Africa, Middle East
From
Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product Type (Diagnosis, Treatment); End User (Hospital, Diagnostic Laboratories, Others), and Geography - Product Thumbnail Image

Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product Type (Diagnosis, Treatment); End User (Hospital, Diagnostic Laboratories, Others), and Geography

  • Report
  • September 2020
  • 215 Pages
  • Global
From
Chronic Kidney Disease Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Chronic Kidney Disease Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Lupus Nephritis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Lupus Nephritis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Kidney Transplantation Therapeutics Market 2024-2028 - Product Thumbnail Image

Kidney Transplantation Therapeutics Market 2024-2028

  • Report
  • January 2024
  • 171 Pages
  • Global
From
Loading Indicator

The Liver and Kidney Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs to treat diseases and disorders of the liver and kidneys. These drugs are used to treat a variety of conditions, including hepatitis, cirrhosis, kidney failure, and other kidney-related diseases. The market is highly competitive, with many companies vying for market share. The market is driven by the increasing prevalence of liver and kidney diseases, as well as the development of new treatments and technologies. Additionally, the rising demand for better treatments and the increasing availability of generic drugs are also contributing to the growth of the market. Some of the major companies in the Liver and Kidney Disorders Drugs market include Pfizer, Merck, Novartis, Sanofi, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, and AbbVie. These companies are engaged in the development and production of drugs to treat liver and kidney diseases. Show Less Read more